Business News:

Do you have a press release about your business? There is no need for you to pay us for posting your press release - you can post for free right now. More »

International News:

You can even break international news here as well. More »

Hobby News:

Have a passion for motorcycles? Post your release about your motorcycle club here and get more eyes and clicks to your website. More »

Sign up today!

Before you can do anything you need to sign up! More »

Post your press release here

Post your press release here and promote your resource More »

 

Medication Management System Market Intelligence Report Offers Growth Prospects

Medication management systems are the systems that are intended to support the medicine management cycle. The medicine management systems are used by the healthcare service provides in order to prevent the adverse drug events. The medication management system in hospitals can be used for supplying, prescribing and administering of medicines. This procedure helps in reducing error rate during medicine administration of prescription based and over-the-counter drugs. The introduction of new products and technologies are gaining attention of healthcare service providers to reduce the complications in drug administration and clinical decisions. For example, the CSC’s Medication Management solution which provides a complete web base solution, helps the hospitals to easily extend its operations. The developing countries provides enormous potential for the medication management system market owing to the high rate of adoption of medication management system.

Medication Management System Market: Drivers and Restraints:

Increasing prevalence of infectious disease, autoimmune disease and others has significantly enhanced the outpatient visits across the globe. This increase in number of outpatient visits has ultimately increased the drug prescription which requires continuous monitoring during the course of treatment. Moreover, the increasing number of aging population suffering from chronic disorders would results in elevated demand for the medication management system. Thus, driving the growth of medication management systems market. Medication management systems facilitates drug management by reducing the cost and time. The restraining factors for the medication management system market are high cost of services and limited adoption rate of the systems.The medication management system market is anticipated to grow with a significant CAGR owing to the increase in number of prescriptions, rising pressure to reduce medication errors and increasing healthcare expenditure.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1419

Medication Management System Market: Segmentation:

The global medication management system market are classified on the basis of type of system, end use and geography.

Based on the type of system, the global medication management system market is divided into following:

  • Automated Dispensing Systems
  • Inventory Management
  • Administration system
  • Clinical Decision Support System

Based on end user, the global medication management system market is divided into following:

  • Hospitals
  • Clinics
  • Retail Pharmacy
  • Ecommerce

Medication Management System Market: Overview:

The increased awareness about medication management system is giving rise to the adoption of these systems. The elimination of errors in medication helps the patient in getting better treatment and cure. The adoption rate of medication management system in hospitals is comparatively high and is estimated to be the fastest growing segment. The automated dispensing system segment are used forthe administration of unit dosage to the patients. These system have higher adoption rate owing to the effective utilization of resources and thus has a positive impact on medication management system market. Inventory management system segment is expected to hold significant share in the medication management system as it deals with the management of medications stored, which is a time consuming task.

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1419

Medication Management System Market: Regional Overview:

On the basis of geography, the global medication management system market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan, and Middle East & Africa. North America hold major share in medical management system market. European countries are expected to represent significant growth rates due to the growth in healthcare practices. Amongst the Asian countries, India and China are more promising countries owing to large population pool, increased prevalence of infectious diseases, increasing awareness, rapid improvement in healthcare services and saturation in the developed markets.

Medication Management System Market: Key Players

Some of the key players in medication management system market are Cerner Corporation, Siemens Healthcare, Allscripts Healthcare Solutions, Inc., CareFusion Corporation, McKesson Corporation, Swisslog, Omnicell, Inc., Becton, Dickinson and Company, Mindray Medical International Limited, and Koninklijke Philips N.V. The focus of these manufacturers is to develop new technologies which would reduce the medication errors and improve medication safety as compared to that of the products available commercially.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/medication-management-system-market

Share Button

Patient Mechanical Lift Handling Equipment Market Estimated to Expand at a Robust CAGR over 2025

Global Patient Mechanical Lift Handling Equipment Market: Overview

Patient mechanical lift handling equipment are lifts that are used to lift patients who are either unable to move or whose weight makes it unsafe to move or lift them manually. These equipment find application in hospitals, homecare, and elderly care homes. The different types of mechanical lifts available in the market are floor-based lifts, stand up and raising lifts/aids, powered sit-to-stand lifts, overhead/ceiling lifts, gantry lifts, and bath patient lifters. All these types of patient lifts function together to facilitate total patient transfer.

Obtain Report Details @ http://www.transparencymarketresearch.com/patient-mechanical-lift-handling-equipment-market.html

Global Patient Mechanical Lift Handling Equipment Market: Key Trends

A number of factors are responsible for promoting the global patient mechanical lift handling equipment market. Some of them are the rising number of accidents and increasing disabilities, spike in the elderly population, the risk of musculoskeletal injuries among caregivers in the process of manual handling of patients, and rules forbidding manual handling of patients. Besides, rise in obesity, which causes people to lose their mobility, has also helped promote the market. In fact, as per the Institute for Health Metrics and Evaluation, around 30% of the global population were either obese or overweight in 2013.

On the contrary, lack of proper budget allocation and dearth of awareness among patients, mostly in developing and under-developed regions of the world about mechanical lift handling equipment, is slated to dampen the growth in the market, particularly in Asia-Pacific and Latin America.

Global Patient Mechanical Lift Handling Equipment Market: Market Potential

Among the various types of mechanical lift handling equipment available in the market, the powered sit-to-stand lifts segment leads with a dominant share. Going forward, it is predicted to retain its dominant position, owing to the emergence of automated lifts that provide enhanced safety and comfort to the patients. Hospitals, these days, are increasingly leveraging expensive mechanical lifts. This has also resulted in their substantial market share.

As per the Bureau of Labor Statistics, around 50% nurses incur back pain and musculoskeletal injuries on account of manual handling of patients. To bring down such injuries, the U.S. government has created a “minimal lift” regulation. Further, many hospitals and healthcare facilities, namely Stanford Hospital and Clinics, have implemented Safe Patient Handling and Mobility Program to reduce risk of injuries among healthcare professionals. All these will create opportunities in the global patient mechanical lift handling equipment market in the future.

Global Patient Mechanical Lift Handling Equipment Market: Regional Outlook

Geographically, the key segments of the global patient mechanical lift handling equipment market are Asia Pacific, Europe, North America, and the Rest of the World. Currently, North America and Europe are key regions on account of the spike in the elderly population, increasing instances of obesity, rise in the incidence of musculoskeletal injuries, effective government regulations, favorable reimbursement policies, and high spending capacity of patients.

In the years ahead, Asia-Pacific and Latin America, will emerge as lucrative markets because of burgeoning urbanization, increasing disposable incomes, rising awareness about patient lifts, increasing instances of obesity, and a rapidly growing elderly population. The rapidly expanding developing economies of China and India along with Japan, which has a large geriatric population, are at the forefront of driving growth in Asia Pacific.

Fill the form for an exclusive sample of this report @ http://bit.ly/2m0Kzav

Global Patient Mechanical Lift Handling Equipment Market: Competitive Analysis

To assess the competition prevailing in the global mechanical lift handling equipment market, the report profiles companies such as Stryker Corporation, Hill-Rom Holdings, Inc., Invacare Corporation, and Getinge Group.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Share Button

Hemophilia Treatment Drugs Market – Evolving Technology, Trends and Industry Analysis – 2024

The global hemophilia treatment drugs market is presently catering to various sub-types of hemophilia such as hemophilia A, hemophilia B and others such as acquired hemophilia and hemophilia C. The increasing awareness of this disorder and the introduction of innovative ways of managing this disease has opened up several opportunities for the global market in recent years. According to the research report, the global hemophilia treatment drugs market was valued at US$15.8 bn in 2015 and is expected to reach US$25.1 bn in 2024, as the market is projected to progress at a CAGR of 5.4%.

The global market is also estimated to benefit from the several blockbuster drugs in the existing portfolio. Presently, these drugs are contributing to the major share of the revenue of the market. The introduction of new drugs and FDA approvals for clinical trials to launch blockbuster treatments is expected to drive this market in the coming years. The commercial availability of promising drugs is anticipated to change the way hemophilia is managed and treated for many patients during the forecast period.

On the basis of product, the global market is segmented into recombinant coagulation factor concentrates, desmopressin, plasma derived coagulation factor concentrates, and antifibrinolytic agents. Out of these products, the recombinant coagulation factor concentrates are expected to dominate the global market in the coming years. The growing preference of medical practitioners for these therapies due to low risk of blood borne infections is anticipated to drive this segment. In 2015, the recombinant coagulation factor concentrates segment held a share of 46.6% in the global market in terms of revenue. This segment is further divided into factor VIII, factor IX and combination drugs.

For more information on this report, fill the form @http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1900

In terms of geography, the global hemophilia treatment drugs market is categorized into Europe, Asia Pacific, North America, Latin America, and the Middle East and Africa. Out of these regions, North America has been leading the global market for a few decades and is expected to continue its stance in the coming years due to well-established healthcare infrastructure. Furthermore, the growing awareness about the disease in the region is also expected to boost sales of products in the coming years.  Currently, the U.S. is leading the hemophilia drugs market in North America.

On the other hand, Europe is anticipated to lose its share as several top-selling drug brands are experiencing patent cliff. Presently, the U.K is leading the Europe market. Asia Pacific is also anticipated to offer several lucrative opportunities to the overall market due to an exponentially growing demand for unmet medical needs. The rising per capita income, improving healthcare facilities, growing awareness about the disorder, and emerging economies of Asia Pacific have lent a significant impetus to the overall market. Additionally, increasing focus on treating bleeding disorders across Asia Pacific and Latin America are also expected give the overall market a remarkable boost in the coming few years.

Some of the key players operating in the global hemophilia treatment drugs market are Shire Plc, Biogen, Pfizer Inc., Novo Nordisk A/S, CSL Behring, F. Hoffmann-La Roche Ltd., Bayer AG, Biotest AG, Kedrion Biopharma Inc., and Octapharma AG. The competitive landscape of the global market can be described as a consolidated one with top ten players holding a mammoth share in the overall market in terms of revenue. Over the coming years, these companies are expected to show a keen interest in expanding their geographical reach and widening their presence in various parts of the world.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Share Button

Medical Imaging Software Market Dynamics, Forecast, Analysis and Supply Demand 2016-2026

Medical imaging software supports in the picturing of the tissues, organs or other body parts for medical diagnosis, treatment and disease supervision. Imaging methods include the fields of magnetic resonance, nuclear medicine, radiography, ocular imaging and other image guided intervention. It aids in processing and forming pictorial representations of the internal parts of body for medical investigation, also to study physiology. They are applicable in wide areas of medical image visualization, computer aided surgical planning, computer added intervention, medical image visualization, molecular imaging etc. Medical imaging software are used for the advancement of patient care and improved operating productivity by empowering doctors and other healthcare professionals with ease of handling and greater flexibility.

The medical imaging software market is growing with increase in demand for technically advanced market for imaging devices. Rapid technological innovations has derived a lot of changes in clinical diagnosis, treatment and disease monitoring.

Request Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-1418

Medical Imaging Software Market: Drivers and Restraints

Medical imaging software global market is driven by the scientific improvement in healthcare segment, escalation in number of medical imaging devices around the world. Also there are some factors for the growth of medical imaging software global market such as rise in the number of diagnostic centers, increase in the aging population and growth in incidence and prevalence of chronic disease. Though, high cost related with clinical validation act as a major barrier for medical imaging software global market.

Medical Imaging Software Market: Segmentation

Medical imaging software global market is segmented into following types:

  • Based on Application
    • Radiography
    • MRI
    • Photoacoustic imaging
    • Nuclear Medicine
    • Echocardiography
    • Tomography
    • Ultrasound
    • Thermography
  • By Region
    • North America
    • Latin America
    • Western Europe
    • Eastern Europe
    • APEJ
    • Japan
    • MEA

Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-1418

Medical Imaging Software Market: Overview

Due to fast technological development, increase in number of diagnostic centers, increase in the elderly population, increasing demand for better result, increase in the incidence and prevalence of disease, and increase in the number of clinical diagnosis around the globe, the medical imaging software global market is expected to have a healthy growth rate in the forecast period.

Medical Imaging Software Market: Region-wise Outlook

Depending on geographic regions, global medical Imaging software market is segmented into seven key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific Excluding Japan, Japan and Middle East & Africa. North America is the leading market for medical imaging softwaredue to rapid technological innovations, huge investment on research and development in this region. Whereas, Europe and Asia-Pacific is projected to grow at a significant growth owing to large consumer base, rising administration initiatives for enhancing healthcare infrastructure will contribute to the global medical imaging software global market value exhibiting a robust CAGR during the forecast period, 2016-2026.

Full Report Analysis@ http://www.futuremarketinsights.com/reports/medical-imaging-software-market

Medical Imaging Software Market: Key Players

Some of the key participating global players in medical Imaging software market are GE Healthcare, Agfa Healthcare, Hitachi Medical Corporation, Infosys Limited Hologic, Esaote SpA, Carestream Health, Shimadzu Corporation, Philips Healthcare and others.

Share Button

Prostate-specific Antigen (PSA) Testing Market: Advanced Technologies, Growth, Trends and Future Outlook 2024

Prostate-specific antigen (PSA) is a type of protein produced by cells of the prostate gland. This protein is usually found in semen, but small quantities of PSA can be detected in the blood of healthy men. High level of the protein is likely to indicate the presence of prostate cancer. Along with the prostate cancer, a number of noncancerous or benign conditions can lead to a rise in the PSA level of a man. Prostatitis is an inflammation of the prostate gland while benign prostatic hyperplasia is an enlargement of the prostate gland. These two conditions are the most common benign prostate conditions which lead to elevation in the levels of PSA. There is no evidence as such that benign prostatic hyperplasia or prostatitis causes prostate cancer, but it is possible for a man to have either of these conditions and develop prostate cancer.

Men who show symptoms linked to prostate cancer can have a PSA test in addition to digital rectal exam (DRE). Symptoms associated with prostate cancer include painful or burning urination, pain during ejaculation, swelling in pelvic area or legs, and loss of bladder control. The PSA level in most men is under 4 ng/mL. This value has been traditionally used as a benchmark for the risk of prostate cancer. Men with normal prostate glands and PSA levels less than 4 ng/ml have about 15% chance of having prostate cancer. The PSA levels are higher in men with prostate cancer which is more than the benchmark value. Hence, it is observed that a man with a high PSA level is more likely to get prostate cancer in comparison with a man with low level; although, there is no such normal and abnormal ranges of PSA in the blood.

Major contributors to the growth of the global prostate-specific antigen (PSA) testing market are increase in adoption of serum-based marker testing for the diagnosis of prostate cancer along with its evaluation with other developing cancer-specific markers, which enhances the overall sensitivity of the test. However, risk of overtreatment and overdiagnosis due to PSA screening can hinder the growth of this market.

The global PSA testing market is segmented based on type, end-user, and geography. The market based on test type is classified into total prostate-specific antigen (PSA) test, free prostate-specific antigen test, and complex prostate-specific antigen test. In terms of end-user, the market is divided into hospitals, diagnostic centers, and clinics.

In terms of geography, the global market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Among the regions, North America is expected to dominate the market and is likely to be closely followed by Europe as prostate cancer is the most common form of cancer found in men in these regions. According to an American Cancer Society report in 2016, the estimates for new cases and deaths related to prostate cancer in the U.S. were about 161,360 and 26,730, respectively.

For more information on this report, fill the form @http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=20843

Prostate cancer is one of the three leading causes of cancer deaths in American men, trailing behind lung and colorectal cancer. As per the report, it is estimated that 1 out of 39 men is likely to die of prostate cancer in lifetime. The Asia Pacific market is expected a fast growth due to increasing prevalence of prostate-related disorders. Other regions such as Middle East & Africa and Latin America are estimated a steady growth of the market due to rise in awareness levels about prostate cancer.

The prominent players operating in the PSA testing market are Abbott Laboratories, Inc., Beckman Coulter, Inc., Bayer AG, Bristol-Myers Squibb Company, Boston Scientific Corporation, Endocare, Inc., GlaxoSmithKline plc, GE Healthcare, Merck & Company, Inc., Medtronic, Inc., Sanofi-Aventis SA, and Urologix, Inc.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Share Button
'
23P-CH8D-XH8X-DC9A-CLR7